期刊文献+

利用重叠延伸PCR技术进行定点突变研究 被引量:12

Site-directed Mutagenesis Based on Overlap Extension PCR
下载PDF
导出
摘要 [目的]建立一种高效、便捷、经济的DNA定点突变方法。[方法]以重组人组织型纤溶酶原激活剂rPA(Reteplase)基因为模板,采用重叠延伸PCR技术对3个位点进行定点突变,将突变基因片段克隆到克隆载体pEASY-Blunt上,并通过测序验证突变结果。[结果]测序结果表明3个位点的突变结果与预期完全一致,即第10位引入单个碱基A、第137位碱基C突变为G以及第686位碱基G突变为A,通过重叠延伸PCR技术一次引入3个突变碱基,100%的实现目的位点的定点突变。[结论]该研究成功实现目的位点的定点突变,为rPA基因的进一步克隆和功能研究奠定了基础。同时也表明重叠延伸PCR技术是一种高效、便捷、经济的DNA定点突变方法。 [Objective] To establish an efficient,convenient and economical method for site-directed mutagenesis.[Method] The target mutation was introduced into primers designed by DNAMAN5.0 software.Through overlap extension PCR for twice obtained the mutation gene which of the full length of the recombinant Human Tissue type plasminogen activator(Reteplase).The mutation gene cloned it into pEASY-blunt simple cloning vector for sequencing.[Result] The sequencing results showed that three site mutations were fully consistent with the expected results(10th site had been added a base-pair of A,C had been changed into G at 137th site,G had been changed into A at 686th site).Three site mutations were introduced by using overlap extension PCR on one-step.The overall rate of obtaining the mutant sites was 100%.Site-directed mutagenesis will clone the recombinant Human Tissue type plasminogen activator and laid the basis for the functional study.[Conclusion] Site-directed mutagenesis was successfully implemented based on the overlap extension PCR which is an efficient,convenient and economical DNA-directed mutagenesis method.
出处 《安徽农业科学》 CAS 2012年第10期5779-5781,共3页 Journal of Anhui Agricultural Sciences
基金 国家自然科学基金资助项目(31160032)
关键词 重叠延伸PCR技术 定点突变 rPA基因 Overlap extension PCR Site-directed mutagenesis Human Tissue Plasminogen Activator(Reteplase)
  • 相关文献

参考文献5

二级参考文献60

  • 1张浩,毛秉智.定点突变技术的研究进展[J].免疫学杂志,2000,16(z1):108-110. 被引量:19
  • 2王宝利,梁晖,戴芳,郭刚,张镜宇.重叠延伸PCR法在合成人骨保护素N端编码序列中的应用[J].天津医科大学学报,2004,10(3):343-345. 被引量:15
  • 3罗师平,冷希岗.基于PCR的体外诱变技术[J].国外医学(生物医学工程分册),2005,28(3):188-192. 被引量:25
  • 4熊爱生,姚泉洪,章镇,彭日荷,庄静,徐芳,刘金戈,朱宏.基因的推理设计与改造——体外分子进化的捷径[J].遗传,2006,28(1):92-96. 被引量:8
  • 5MCPHERSON L A, WEIGEL R J. AP-2 α and AP-2 γ: a comparison of binding site specificity and transactivation of the estrogen receptor promoter and single site promoter constructs[J]. Nucleic Acids Research, 1999, 27(20): 4040- 4049.
  • 6MITCHELL P J, WANG C, TJIAN R. Positive and negative regulation of transcription in vitro: enhancer binding protein AP-2 is inhibited by SV 40 T antigen[J]. Cell, 1987, 50: 847-861.
  • 7PELLIKANEN M J, PEKOLA T T, ROPPONEN K M, et al. p 21 WAF1 expression in invasive breast cancer and its association with p 53, AP-2, cell proliferation, and prognosis [J]. Clin Pathol, 2003, 56 (3): 214-220.
  • 8MCPHERSON L A, WEIGEL R J. AP-2 α and AP-2 γ: a comparison of binding site specificity and transactivation of the estrogen receptor promoter and single site promoter constructs[J]. Nucleic Acids Research, 1999, 27(20): 4040-4049.
  • 9PERISSIV, MENNIN, COTTONE E, et al. AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen[J]. Oncogene, 2000, 19 (2) : 280-288.
  • 10JEAN D, GERSHENWALD J E, HUANG S, et al. Loss of AP-2 results in upregulation of MCAM/MUC 18 and an increase in tumor growth and metastasis of human melanoma cells[J]. J Biol Chem, 1998, 273 (26): 16501-16508.

共引文献71

同被引文献140

引证文献12

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部